Commercialization strategy for FormaCyte therapeutics: Type 1 diabetes patient insights and regulatory pathway analysis on US FDA's impact on other jurisdictions

This report aims to strengthen the commercialization strategy of FormaCyte, an innovative treatment for Type 1 Diabetes (T1D), by obtaining firsthand patient insights to bolster a patient-centered development and investigating the US’s regulatory impact for cell therapy on other jurisdictions to...

Full description

Saved in:
Bibliographic Details
Main Author: Liu, Fanzheng
Other Authors: Dang Thuy Tram
Format: Final Year Project
Language:English
Published: Nanyang Technological University 2024
Subjects:
Online Access:https://hdl.handle.net/10356/177416
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
Be the first to leave a comment!
You must be logged in first